SCHEMBL5773765

SCHEMBL5773765

C=C(c1ccc(OC)c(F)c1)N1CCCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.51
HTT P42858 2/20 0.51
MAPK1 P28482 1/20 0.51
RAB9A P51151 1/20 0.51
ALOX15 P16050 1/20 0.50
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
ALDH1A1 P00352 7/20 0.47
HPGD P15428 4/20 0.47
DUSP3 P51452 2/20 0.47
GFER P55789 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MAPT P10636 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
PTPN7 P35236 1/20 0.46
PTPN5 P54829 1/20 0.46
PTPN11 Q06124 1/20 0.46
L3MBTL1 Q9Y468 4/20 0.44
TP53 P04637 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5774957 0.86 SMN1; SMN2 (0.58) LMNAMAPK1RAB9AALOX15KMT2A
SCHEMBL8324482 0.81 HPGD (0.63) LMNAHTTMAPK1RAB9AKMT2A
SCHEMBL5769961 0.80 MEN1 (0.46) LMNAHTTRAB9AKMT2AMEN1
SCHEMBL22593163 0.75 ALOX15 (0.41) LMNAALOX15KMT2AMEN1ALDH1A1
SCHEMBL15691255 0.75 HTT (0.68) LMNAHTTMAPK1RAB9AKMT2A
SCHEMBL5772555 0.74 ALDH1A1 (0.70) KMT2AMEN1ALDH1A1HPGDDUSP3
SCHEMBL5949604 0.74 SMN1; SMN2 (0.66) LMNAHTTALOX15KMT2AMEN1
SCHEMBL7185944 0.73 CES2 (0.40) LMNAHTTRAB9AKMT2AMEN1
SCHEMBL5774166 0.72 CHRNA1 (0.52) LMNAHTTRAB9AKMT2AMEN1
SCHEMBL7182897 0.72 HPGD (0.50) MAPK1ALOX15KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed